Should You Buy Immunomedics Before the Gilead Sciences Acquisition Closes?

Should You Buy Immunomedics Before the Gilead Sciences Acquisition Closes?

Motley Fool

Published

The company's recent acquisition at a lofty premium looks similar to other Gilead deals. That could mean one of two things for investors.

Full Article